Amazon Adds Drug Information to its mHealth Platform for Alexa

A new mHealth partnership will give Amazon Alexa users detailed information on the drugs they’re taking, adding a new dimension of care management to digital health assistants. Amazon announced the partnership today with First DataBank, the San Francisco-based provider of drug and medical device information. The deal will give Alexa users access to information provided by FDB clinicians on a wide variety of drugs, as well as precautions, interactions and side effects. People lead busy lives and voice provides a simple way to get helpful information about medications including side effects and drug interactions – for themselves and the people they care for – and this information will complement advice from their medical and pharmacy teams,” FDB President Bob Katter said in a press release. “Ultimately, we believe that more informed consumers will lead to improved medication adherence, the reduction of adverse drug events, and better patient outcomes.”